NPSP

Biotech Stocks in Motion – Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma

LONDON, November 24, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 21, 2014, the NASDAQ Composite ended at 4,712.97, […]

NPS Pharmaceuticals’ (NPSP) CEO Francois Nader on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Francois Nader Thank you, Susan, and good morning everyone. Thank you for joining us on today’s call. 2014 continues to be an important growth year for NPS Pharma as we are focusing on our four strategic … moreView todays social media effects on NPSPView the latest stocks trending across Twitter. Click to view dashboardSee who NPS […]

NPS Pharma Reports First-Quarter 2014 Financial Results

[Business Wire] – NPS Pharmaceuticals, Inc. , a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today re moreView todays social media effects on NPSPView the latest stocks trending across Twitter. Click to view dashboardSee who NPS is hiring next, click here to view […]